cisplatin and paclitaxel

DRUG2 trials

Sponsors

Henan Cancer Hospital, Dr. Munshi Md. Arif Hosen

Conditions

Advanced non small cell lung cancer NSCLC Cisplatin Etoposide PaclitaxelEsophageal Neoplasm

Phase 3

Neoadjuvant Chemotherapy Versus Surgery Alone for Esophageal Squamous Cell Carcinoma

CompletedNCT02395705

Henan Cancer HospitalEsophageal Neoplasm

Start: 2015-06-30End: 2022-10-31Target: 528Updated: 2022-10-05

Response of chemotherapy with cisplatin and etoposide versus cisplatin and paclitaxel in advanced non-small cell lung cancer patient

Active, not recruitingTCTR20181011005

Dr. Munshi Md. Arif HosenAdvanced non small cell lung cancer NSCLC Cisplatin Etoposide Paclitaxel

Start: 2017-01-01Updated: 2026-08-03

Related Papers

The lost evidence: A phase III, multicenter randomized controlled trial of neoadjuvant chemotherapy paclitaxel plus cisplatin versus surgery alone for stage IIA–IIIB esophageal squamous cell carcinoma.

Journal of Clinical Oncology2025-05-28

Multi-region sequencing reveals genetic correlation between esophageal squamous cell carcinoma and matched cell-free DNA.

2021-08-301 citations